Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Risk for Pulmonary Embolism Continues Beyond 6 Weeks of Surgery

Guidelines recommend postoperative prophylactic anticoagulation for 1-5 weeks.

Atherosclerotic Cardiovascular Disease Risk Assessment

VTE Comparison of Pregnancy - Specific Risk Scoring Systems in Hospitalized Maternity Patients

Large prospective clinical trials are needed to validate the scoring threshold for pharmacoprophylaxis.

Measures of disease severity in eosinophilic esophagitis (EoE)

Utility of Pregnancy - Adapted Years Algorithm in Diagnosis of Pulmonary Embolism

Findings from a multicentre prospective Artemis study.

Take a Stand Against Influenza: Focus on Cardiovascular Disease Patients

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

Event rates and Risk Factors for Recurrent CV Events

New technologies in Type 2 Diabetes management and future opportunities to improve clinical outcomes

This session emphasizes that new technology in Diabetes management not only can overcome common barriers in achieving glycemic control in people with T2D but also may facilitate more effective and efficient Diabetes care.

Act Now for Your ACS Patients: Optimize Your ACS Pathway

Sanofi Pasteur at Glance

PCSK9 Inhibitors in Cardiovascular Disease